Dual Inhibition of Ornithine Decarboxylase and A1 Adenosine Receptor Efficiently Suppresses Breast Tumor Cells

Dual Inhibition of Ornithine Decarboxylase and A1 Adenosine Receptor Efficiently Suppresses Breast Tumor Cells

Personized treatment of breast cancer is still a challenge, and more treatment options for breast cancer are warranted. Combination therapies have been a highly appreciated strategy for breast cancer treatment in recent years, and the development of new combination therapies could improve patient ou...

Full description

Bibliographic Details
Main Authors: Hongyan Ma, Qizhang Li, Jing Wang, Jing Pan, Zhengding Su, Sen Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
dual inhibitor
ornithine decarboxylase 1 (ODC)
A1AR
polyamine pathway
cyclic AMP (cAMP) pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.636373/full

Similar Items

Similar Items